National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

Science Serving People

Español
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate

Denosumab May Help Prevent Bone Loss

Past Highlights
   
 
Results: 1 -10 of 26         results per page
View Search Criteria | Help With Results
           

1.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase III, Phase II


Treatment


Active


18 and over


Pharmaceutical / Industry


D8480C00013
Eudract Number 2005-003440-66, NCT00384176


2.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase III


Treatment


Active


18 and over


Pharmaceutical / Industry


D8480C00051
EUDRACT No 2006-001194-14, HORIZON II, NCT00399035

Last Modified: 11/2/2007     First Published: 10/5/2007  

3.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase III


Treatment


Active


18 and over


Other, Pharmaceutical / Industry


MRC-NCRI-ICON6
MRC-NCRI-ICON6, EUDRACT-2007-001346-41, EU-20765, ZENECA-MRC-NCRI-ICON6, NCT00544973


4.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase II, Phase I


Treatment


Active


18 and over


Pharmaceutical / Industry


D8480C00039
NCT00494221

Last Modified: 5/21/2008     First Published: 4/17/2008  

5.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase II, Phase I


Biomarker/Laboratory analysis, Treatment


Active


18 and over


NCI


MGH-07-344
07-344, 8030, NCT00662506

Last Modified: 9/21/2007     First Published: 10/14/2005  

6.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase II


Treatment


Active


18 and over


NCI


PMH-PHL-038
7137, NCT00243061

Last Modified: 11/2/2007     First Published: 12/22/2005  

7.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase II


Treatment


Active


18 and over


NCI


DFCI-05170
NCI-7102, 7102, NCT00275028

Last Modified: 5/13/2008     First Published: 3/24/2006  

8.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase II


Biomarker/Laboratory analysis, Treatment


Active


18 and over


NCI


UCCRC-14203B
NCI-7103, 7103, NCT00309946

Last Modified: 10/9/2008     First Published: 5/11/2006  

9.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase II


Biomarker/Laboratory analysis, Treatment


Active


18 and over


NCI


NCCTG-N0528
N0528, NCT00326599

Last Modified: 5/8/2007     First Published: 5/11/2006  

10.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase II


Treatment


Active


18 and over


NCI


MAYO-MC047F
7133, NCI-7133, NCT00326872

   
    1 2 3   Next >

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov